Clinical Presentation and Outcomes After Surgery for Mitral Regurgitation: Real-World Insights From the MITRACURE International Registry
Circulation · 30.09.2025 · 152 (13) · 927-938
DOI: 10.1161/circulationaha.124.073674 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation, erschienen am 30.09.2025. Verfasst von David Messika-Zeitoun und 52 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada (D.M.-Z., A.Y.N.F., R.G.). Hauptthemen laut MEDLINE: Mitral Valve, Mitral Valve Insufficiency. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Edwards Lifesciences.
Abstract (Originalsprache)
BACKGROUND: Comprehensive knowledge of the clinical presentation, contemporary management, and outcomes on “all-comer” patients referred for mitral valve surgery (MVS) are critical to evaluate current practice and adherence to guidelines, understand selection biases, and inform key stakeholders on quality improvement. METHODS: MITRACURE is a large international retrospective registry of consecutive adult patients who underwent isolated or combined MVS for mitral regurgitation (MR) in France or Canada in 2019 with in-depth clinical and echocardiographic characterization. Patients operated on for isolated mitral stenosis or who had a prior mitral valve intervention were excluded. Data were obtained from detailed chart abstraction and were site reported. RESULTS: In 2019, 3522 patients underwent MVS (48% combined) across 40 centers (88±46 MVSs/center, median 80, interquartile [51–131]). Mean age was 65±12 years, and 35% were women. The most common MR etiology was myxomatous (61%), followed by functional (9%), infective endocarditis (9%), and rheumatic disease (7%). MR quantification was performed in only 43%. Advanced clinical presentation was common: 43% were in New York Heart Association class III/IV, 30% exhibited congestive heart failure, 47% were on diuretics, 22% had atrial fibrillation/flutter, 35% presented with reduced ejection fraction, and 22% had pulmonary hypertension (≥50 mm Hg). Most patients were symptomatic or presented with class I/IIa indication for intervention, and an early intervention was performed only in 3% of patients. The repair rate was 62% overall and 80% in myxomatous disease. In-hospital mortality was 4.5% overall but 2.3% in patients with myxomatous MR (1.8% isolated, 3.1% combined). CONCLUSIONS: MITRACURE provides a contemporary, multicenter, “real-world” picture of the clinical presentation, management, and in-hospital outcomes of MVS for MR in two Western countries. Patients were often referred late in the disease process, with few patients undergoing early intervention. The higher mortality and lower repair rates reported may be more reflective of an unselected MR patient population but have room for improvement. Our results underline the need to develop strategies to improve management and outcomes of patients with MR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada (D.M.-Z., A.Y.N.F., R.G.).
- Division of Cardiac Surgery, Department of Surgery, Western University, London, ON, Canada (M.W.A.C., L.G.).
- Department of Surgery, Montreal Heart Institute, Montreal, QC, Canada (D.B., P.D.).
- Université de Nantes, CHU de Nantes, CNRS, INSERM, L'institut du Thorax, 44000 Nantes, France (T.L.T.).
- Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, 33600 Pessac, France (J.T.).
- INSERM, Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, 33604 Pessac, France (J.T.).
ORCID-Profile: David Messika-Zeitoun, Michael W A Chu, Denis Bouchard, Thierry Le Tourneau, Julien Ternacle, Angel Yi Nam Fu, Jean Claude Dib, Thays Sokolov, Amedeo Anselmi, Didier Tchétché, Ophélie Brault Meslin, Yoan Lavie-Badie, Augustin Coisne, Anne Bernard, Malek Kass, Antonio Fiore, Arnaud Maudiere, Yohann Bohbot, Nadjib Hammoudi, Loïc Bière, Jessica Forcillo, Christine Selton-Suty, Martine Gilard, Claire Bouleti, Jean-Francois Legare, Thiziri Si Moussi, Jian Ye, Bindu Bittira, Laura Munte, Fabrice Bauer, Jordan Bernick, George A Wells, Bernard Iung, William D T Kent, Jean-François Obadia, Julien Dreyfus
Förderung
- Edwards Lifesciences
Zitieren
APA
Messika-Zeitoun, D., Chu, M. W. A., Bouchard, D., Le Tourneau, T., Ternacle, J., Demers, P., Guo, L., Fu, A. Y. N., Dib, J. C., Lam, C., Sokolov, T., Anselmi, A., Tchétché, D., Brault Meslin, O., Goutondji, A., Lavie-Badie, Y., Seknadji, P., Coisne, A., Arangalage, D., …, & MITRACURE Investigators (2025). Clinical Presentation and Outcomes After Surgery for Mitral Regurgitation: Real-World Insights From the MITRACURE International Registry. Circulation, 152(13), 927-938. https://doi.org/10.1161/circulationaha.124.073674
Vancouver
Messika-Zeitoun D, Chu MWA, Bouchard D, Le Tourneau T, Ternacle J, Demers P, et al. Clinical Presentation and Outcomes After Surgery for Mitral Regurgitation: Real-World Insights From the MITRACURE International Registry. Circulation. 2025;152(13):927-938. doi:10.1161/circulationaha.124.073674
BibTeX
@article{MessikaZeitoun2025,
author = {Messika-Zeitoun, David and Chu, Michael W A and Bouchard, Denis and Le Tourneau, Thierry and Ternacle, Julien and Demers, Philippe and Guo, Linrui and Fu, Angel Yi Nam and Dib, Jean Claude and Lam, Charmaine and Sokolov, Thays and Anselmi, Amedeo and Tchétché, Didier and Brault Meslin, Ophélie and Goutondji, Ange and Lavie-Badie, Yoan and Seknadji, Patrick and Coisne, Augustin and Arangalage, Dimitri and Bernard, Anne and Manian, Usha and Kass, Malek and Fiore, Antonio and Maudiere, Arnaud and Bohbot, Yohann and Seemann, Aurélien and Hammoudi, Nadjib and Bière, Loïc and Leroux, Pierre-Yves and Forcillo, Jessica and Jeu, Antoine and Elegamandji, Benjamin and Selton-Suty, Christine and Gilard, Martine and Bouleti, Claire and Arshad, Omair and Legare, Jean-Francois and Si Moussi, Thiziri and Ye, Jian and Sportouch, Catherine and Bittira, Bindu and Munte, Laura and Bauer, Fabrice and Ong, Geraldine and Fatehi Hassanabad, Ali and Bernick, Jordan and Wells, George A and Gauda, Roja and Iung, Bernard and Kent, William D T and Obadia, Jean-François and Dreyfus, Julien and MITRACURE Investigators, MITRACURE Investigators},
title = {Clinical Presentation and Outcomes After Surgery for Mitral Regurgitation: Real-World Insights From the MITRACURE International Registry},
journal = {Circulation},
year = {2025},
volume = {152},
number = {13},
pages = {927--938},
doi = {10.1161/circulationaha.124.073674}
}
EUVIMED